U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2853128531Effect Study of Tigecycline to Treat Severe Sepsis and Septic ShockRecruitingNo Results AvailableAbdominal InfectionDrug: glycopeptide plus carbapenem|Drug: Haizheng Li Xing ® plus tazocin ®https://ClinicalTrials.gov/show/NCT02191475
2853228532A Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy SubjectsCompletedNo Results AvailablePharmacokineticsDietary Supplement: Niagen 100mg|Dietary Supplement: Niagen 300mg|Dietary Supplement: Niagen 1000mghttps://ClinicalTrials.gov/show/NCT02191462
2853328533The Influence of Preoperative Warfarin Medication on Thromboelastography and Blood TransfusionCompletedNo Results AvailableAtrial Fibrillationhttps://ClinicalTrials.gov/show/NCT02191449
2853428534Adherence to Treatment in HemophiliaRecruitingNo Results AvailableHaemophiliahttps://ClinicalTrials.gov/show/NCT02191436
2853528535Oxytocin and Dyadic Psychotherapy in the Treatment of Post Partum DepressionNot yet recruitingNo Results AvailablePostpartum DepressionDrug: Oxytocin|Drug: placebo|Behavioral: Dyadic psychotherapyhttps://ClinicalTrials.gov/show/NCT02191423
2853628536Nondependent Lung Ventilation and Fluid ResponsivenessNot yet recruitingNo Results AvailableLung Disease|Undergoing Thoracosocpic SurgeryProcedure: High Frequency Positive Pressure Ventilation|Procedure: Continuous Positive Airway Pressurehttps://ClinicalTrials.gov/show/NCT02191410
2853728537Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive DisorderRecruitingNo Results AvailableDepressive Disorder, MajorDrug: Bupropion|Drug: Bupropion Matching Placebo|Drug: Escitalopram|Drug: Escitalopram Matching Placebohttps://ClinicalTrials.gov/show/NCT02191397
2853828538Comparison of Orcinoside With Placebo in Treatment of MDDRecruitingNo Results AvailableMajor Depressive Disorder (MDD)Drug: Orcinosidehttps://ClinicalTrials.gov/show/NCT02191384
2853928539Effect of Anesthetics on Oxygenation and Microcirculation During One-lung VentilationRecruitingNo Results AvailableMechanical Ventilation ComplicationDrug: propofol|Drug: desfluranehttps://ClinicalTrials.gov/show/NCT02191371
2854028540YouScript IMPACT RegistryCompletedNo Results AvailableAdverse Drug Events|Adverse Drug Reactions|Drug Interaction Potentiation|Drug Metabolism, Poor, CYP2D6-RELATED|Drug Metabolism, Poor, CYP2C19-RELATED|Cytochrome P450 Enzyme Deficiency|Cytochrome P450 CYP2D6 Enzyme Deficiency|Cytochrome P450 CYP2C9 Enzyme https://ClinicalTrials.gov/show/NCT02191358
2854128541The Effectiveness of Guided Imagery for a Nonprofit's EmployeesCompletedNo Results AvailableFocus of Study:|StressBehavioral: Guided Imageryhttps://ClinicalTrials.gov/show/NCT02191345
2854228542Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy RegimenCompletedNo Results AvailableHIV InfectionsDrug: Viramunehttps://ClinicalTrials.gov/show/NCT02191332
2854328543Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) RegimensCompletedNo Results AvailableHIV InfectionsDrug: Viramune®https://ClinicalTrials.gov/show/NCT02191319
2854428544Utilizing Computed Tomographic Angiography to Evaluate Coronary Artery Disease in Patients on Long-Term Antiretroviral TherapyCompletedNo Results AvailableOur Study Aims to Evaluate the Relationship Between HIV Medications and Coronary Atherosclerosis Using Coronary Artery CT Angiography.https://ClinicalTrials.gov/show/NCT02191306
2854528545Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®CompletedNo Results AvailableHIV InfectionsDrug: Viramune® tabletshttps://ClinicalTrials.gov/show/NCT02191293
2854628546Antistax® in Patients With Chronic Venous InsufficiencyCompletedNo Results AvailableVenous InsufficiencyDrug: Antistax®, low dose|Drug: Antistax®, high dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02191280
2854728547Tau Imaging of Chronic Traumatic EncephalopathyEnrolling by invitationNo Results AvailableChronic Traumatic Encephalopathy.Radiation: [F18]-T807|Radiation: [F18]-Florbetapir|Device: MRI/MRS|Genetic: Genetic Analysis for Genetic Risk Score for Tau.https://ClinicalTrials.gov/show/NCT02191267
2854828548Efficacy and Tolerability of Antistax® in Male and Female Patients Suffering From Chronic Venous InsufficiencyCompletedNo Results AvailableVenous InsufficiencyDrug: Antistax®|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02191254
2854928549Pharmacokinetics of a Single Oral Dose of 1,800 mg Red Vine Leaf Extract (Antistax®)CompletedNo Results AvailableHealthyDrug: Red Vine Leaf Extracthttps://ClinicalTrials.gov/show/NCT02191241
2855028550Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal FunctionCompletedNo Results AvailableRenal InsufficiencyDrug: Linagliptin - single dose|Drug: Linagliptin - Multiple dosehttps://ClinicalTrials.gov/show/NCT02191228
2855128551Clinical and Therapeutic Evaluation of the Infection by HIV/AIDSCompletedNo Results AvailableAcquired Immunodeficiency SyndromeDrug: Nevirapine (Viramune®)https://ClinicalTrials.gov/show/NCT02191215
2855228552Impact of Switching to NNRTI-based Therapy on the Quality of Life of HIV-infected Patients With Virological SuppressionCompletedNo Results AvailableHIV InfectionsDrug: Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)https://ClinicalTrials.gov/show/NCT02191202
2855328553Pharmacoscintigraphic Investigation Into the Absorption of Nevirapine When Released Into Different Parts of the Gastro-intestinal Tract in Healthy MalesCompletedNo Results AvailableHealthyDrug: Nevirapine suspension, into Enterionâ„¢ capsule|Drug: Nevirapine suspensionhttps://ClinicalTrials.gov/show/NCT02191189
2855428554Study to Investigate Safety With Special Emphasis on ECG Effects and Tolerability After Oral Doses of Dextromethorphan Hydrobromide Monohydrate in Healthy Male and Female SubjectsCompletedNo Results AvailableHealthyDrug: Dextromethorphan syrup - low dose|Drug: Dextromethorphan syrup - high dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02191176
2855528555Efficacy of Antistax® in Improving Microcirculation of the Skin in the Leg in Patients Suffering From Chronic Venous InsufficiencyCompletedNo Results AvailableVenous InsufficiencyDrug: Antistax®|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02191163
2855628556Study of Haemodialysis Patients Switching From Aranesp to BiosimilarCompletedNo Results AvailableAnaemiahttps://ClinicalTrials.gov/show/NCT02191150
2855728557MOTION, Measuring Outcomes in Treatment Naive PatientsRecruitingNo Results AvailablePulmonaryDrug: Riociguat (Adempas,BAY63-2521)https://ClinicalTrials.gov/show/NCT02191137
2855828558The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled TrialCompletedNo Results AvailableMajor Depressive DisorderDrug: Paroxetine|Drug: Mirtazapinehttps://ClinicalTrials.gov/show/NCT02191124
2855928559A Cluster-randomized Controlled Knowledge Translation Feasibility Study in Alberta Community PharmaciesActive, not recruitingNo Results AvailableChronic DiseasesBehavioral: Task-focused facilitationhttps://ClinicalTrials.gov/show/NCT02191111
2856028560Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected PeopleNot yet recruitingNo Results AvailableHIV|Stable ARTDrug: ALT-803https://ClinicalTrials.gov/show/NCT02191098

* Görseller ve İçerik tekif hakkına sahip olabilir